StonvexLoading…
StonvexStonvexStonvexCore line items from LAZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $784.07M | $779.40M | $3.19B | $2.26B | $1.49B |
Operating Income | Not available | $89.57M | $327.60M | $242.65M | $147.72M |
Net Income | Not available | $100.92M | $236.83M | $186.97M | $115.72M |
EPS (Diluted) | $0.51 | $0.91 | $2.17 | $1.72 | $1.08 |
Total Assets | Not available | $4.24B | $4.94B | $4.63B | $4.49B |
Total Liabilities | Not available | $3.29B | $3.95B | $3.68B | $3.62B |
Cash & Equivalents | Not available | $1.02B | $1.47B | $1.17B | $978.26M |
Free Cash Flow OCF − CapEx | Not available | $-221.45M | $487.38M | $91.26M | $-193.36M |
Shares Outstanding | Not available | 106.79M | 106.34M | 105.91M | 104.87M |